Cargando…

Personalized approach to growth hormone replacement in adults

Growth hormone (GH) deficiency (GHD) in adults is well-characterized and includes abnormal body composition, reduced bone mass, an adverse cardiovascular risk profile, and impaired quality of life. In the early 1990s, it was also shown that patients with hypopituitarism without GH replacement therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Bunderen, Christa C., Glad, Camilla, Johannsson, Gudmundur, Olsson, Daniel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522239/ https://www.ncbi.nlm.nih.gov/pubmed/31939484 http://dx.doi.org/10.20945/2359-3997000000189

Ejemplares similares

Growth hormone deficiency and replacement therapy in adults: Impact on survival
por: van Bunderen, Christa C., et al.
Publicado: (2020)

Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency
por: van Bunderen, Christa C., et al.
Publicado: (2018)

Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)
por: Höybye, Charlotte, et al.
Publicado: (2021)

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study
por: Barbosa, Edna J. L., et al.
Publicado: (2014)

Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression
por: Hallén, Tobias, et al.
Publicado: (2022)

Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives
por: van der Kaay, Danielle Christine Maria, et al.
Publicado: (2022)

Genome-Wide DNA Methylation Differences in Patients With Non-Functioning Pituitary Adenomas With or Without Postsurgical Intervention
por: Hallén, Tobias, et al.
Publicado: (2021)

Reduced DNA methylation and psychopathology following endogenous hypercortisolism – a genome-wide study
por: Glad, Camilla A. M., et al.
Publicado: (2017)

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
por: Johannsson, Gudmundur, et al.
Publicado: (2022)

Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis
por: Yuen, Kevin C J, et al.
Publicado: (2023)

Pseudoacromegaly: A Differential Diagnostic Problem for Acromegaly With a Genetic Solution
por: Dahlqvist, Per, et al.
Publicado: (2017)

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2018)

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency
por: Takahashi, Yutaka, et al.
Publicado: (2022)

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

MON-330 Cancer Incidence in 1,296 Patients with Acromegaly Is Not Increased: A Nationwide Population-Based Study
por: Esposito, Daniela, et al.
Publicado: (2020)

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults
por: van Varsseveld, N. C., et al.
Publicado: (2016)

Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement
por: Ahmid, M, et al.
Publicado: (2016)

GH deficiency and insensitivity in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2021)

Titrating Growth Hormone Dose to High-Normal IGF-1 Levels Has Beneficial Effects on Body Fat Distribution and Microcirculatory Function Despite Causing Insulin Resistance
por: van Bunderen, Christa C., et al.
Publicado: (2021)

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
por: Boguszewski, Margaret C. S., et al.
Publicado: (2021)

SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
por: Johannsson, Gudmundur, et al.
Publicado: (2019)

Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement
por: Reed, Mary L., et al.
Publicado: (2013)

Fifteen years of GH replacement improves body composition and cardiovascular risk factors
por: Elbornsson, Mariam, et al.
Publicado: (2013)

Growth hormone replacement therapy in adults with growth hormone deficiency; thrice weekly low dose administration.
por: Chung, Y. S., et al.
Publicado: (1994)

Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
por: Esposito, Daniela, et al.
Publicado: (2019)

MON-159 High Mortality Rate in Oral Glucocorticoid Users: A Case-Control Study
por: Einarsdottir, Margret, et al.
Publicado: (2020)

Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency
por: Johannsson, G., et al.
Publicado: (2018)

Extended Support Within a Person-Centered Practice After Surgery for Patients With Pituitary Tumors: Protocol for a Quasiexperimental Study
por: Jakobsson, Sofie, et al.
Publicado: (2020)

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
por: Grossman, Ashley, et al.
Publicado: (2013)

Growth Hormone Replacement Therapy: Transition from Adolescence to Adulthood
por: Geffner, Mitchell E.
Publicado: (2009)

Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
por: Esposito, Daniela, et al.
Publicado: (2022)

Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis
por: Li, Zhanzhan, et al.
Publicado: (2016)

Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
por: Boguszewski, Margaret C S, et al.
Publicado: (2022)

High Mortality Rate in Oral Glucocorticoid Users: A Population-Based Matched Cohort Study
por: Einarsdottir, Margret J., et al.
Publicado: (2022)

Effects of Growth Hormone Replacement Therapy on Bone Mineral Density in Growth Hormone Deficient Adults: A Meta-Analysis
por: Xue, Peng, et al.
Publicado: (2013)

GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid Replacement
por: Melvin, Audrey, et al.
Publicado: (2019)

Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
por: Castillo, Alejandro Rosell, et al.
Publicado: (2019)

Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades – Yet An Underdiagnosed Disorder
por: Gkaniatsa, Eleftheria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5atdm1m03hanvprpi84oavqdc5